Market Cap (In INR)
153.34 Billion
Revenue (In INR)
15.58 Billion
Net Income (In INR)
3 Billion
Avg. Volume
48.98 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 4926.05-18100.0
- PE
- 51.11
- EPS
- 233.84
- Beta Value
- 0.98
- ISIN
- INE794A01010
- CUSIP
- Y6272R119
- CIK
- -
- Shares
- 12829900.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Davuluri Sucheth Rao
- Employee Count
- -
- Website
- https://www.neulandlabs.com
- Ipo Date
- 2008-10-13
- Details
- Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was incorporated in 1984 and is headquartered in Hyderabad, India.
More Stocks
-
AZZTFAztec Minerals Corp.
AZZTF
-
3174
-
9602Toho Co., Ltd.
9602
-
GRPNGroupon, Inc.
GRPN
-
1463
-
NIVAKANIVAKA FASHIONS LIMITED
NIVAKA
-
GEX
-
FVJ